Positive Clinical Study Findings for its TeaRx™ Diagnostic Parameters for Dry Eye Syndrome

BioLight announced the completion of a U.S. clinical study, conducted by Ora, Inc. Andover, MA, designed to compare widelyused benchmark tests for dry eye with its TeaRx™ diagnostic parameters that test components of tear film. Positive statistical correlations were identified between TeaRx™ diagnostic parameters and widely used benchmark tests for dry eye syndrome.

Link to complete article

Link to Newsroom

Comments are closed.